Thrombosis and survival in essential thrombocythemia: A regional study of 1,144 patients

American Journal of Hematology

Volumn 89, Issue 5, 2014, Pages 542-546

  Montanaro, Marco ^a   Latagliata, Roberto ^b   Cedrone, Michele ^c   Spadea, Antonio ^d   Rago, Angela ^e   Di Giandomenico, Jonny ^f   Spirito, Francesca ^g   Porrini, Raffaele ^h   De Muro, Marianna ^e   Leonetti, Sabrina Crescenzi ⁱ   Villivà, Nicoletta ^j   De Gregoris, Cinzia ^a   Breccia, Massimo ^b   Montefusco, Enrico ^h   Santoro, Cristina ^b   Cimino, Giuseppe ^e   Majolino, Ignazio ^g   Mazzucconi, Maria Gabriella ^b   Alimena, Giuliana ^b   Andriani, Alesssandro ^j  

^a BELCOLLE HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

^d REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^e Department of Hematology Polo Universitario Pontino ^*  (Italy)

^f UNIVERSITY OF ROME TOR VERGATA   (Italy)

^g SAN CAMILLO HOSPITAL   (Italy)

^h SAPIENZA UNIVERSITY OF ROME   (Italy)

ⁱ SANDRO PERTINI HOSPITAL   (Italy)

^j Digestive Endoscopy Unit   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANEMIA; ARTERY THROMBOSIS; ARTICLE; CARDIOVASCULAR RISK; CLINICAL FEATURE; COHORT ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SPLENOMEGALY; THROMBOCYTHEMIA; THROMBOSIS; THROMBOSIS FREE SURVIVAL; VEIN THROMBOSIS;

AGED; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SURVIVAL ANALYSIS; THROMBOCYTHEMIA, ESSENTIAL; THROMBOSIS;

EID: 84898415131     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23685     Document Type: Article

References (16)

1. Tefferi A. Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management. Am J Hematol 2012;87:285-293.
2. Wolanskyj A, Schwager S, McClure R, et al. Essential Thrombocythemia beyond the first decade: life expectancy, long-term complication rates and prognostic factors. Mayo Clin Proc 2008;81:159-166.
3. Elliott MA, Tefferi A. Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia. Br J Haematol 2005;128:275-290.
4. Bleeker J, Hogan W. Thrombocytosis: Diagnostic evaluation, thrombotic risk stratification and risk-based management strategies. Thrombosis 2011:536062. doi: 10.1155/2011/536062.
5. Cortelazzo S, Finazzi G, Ruggeri M, et al. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. N Engl J Med 1995;332:1132-1136.
6. Finazzi G. How to manage essential thrombocythemia. Leukemia 2012;26:875-882.
7. Tefferi A, Gangat N, Wolanskyj A. The interaction between leukocytosis and other risk factors for thrombosis in essential thrombocythemia. Blood 2007;109:4105.
8. Passamonti F, Rumi E, Arcaini L, et al. Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: A study of 605 patients. Haematologica 2008;93:1645-1651.
9. Carobbio A, Antonioli E, Guglielmelli P, et al. Leukocytosis and risk stratification assessment in essential thrombocythemia. J Clin Oncol 2008;26:2732-2736.
10. Girodon F, Dutrillaux F, Broséus J, et al. Leukocytosis is associated with poor survival but not with increased risk of thrombosis in essential thrombocythemia: A population-based study of 311 patients. Leukemia 2010;24:900-903.
11. Palandri F, Polverelli N, Catani L, et al. Impact of leukocytosis on thrombotic risk and survival in 532 patients with essential thrombocythemia: A retrospective study. Ann Hematol 2011;90:933-938.
12. Carobbio A, Thiele J, Passamonti F, et al. Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: An international study of 891 patients. Blood 2011;117:5857-5859.
13. Barbui T, Finazzi G, Carobbio A, et al. Development and validation of an International Prognostic Score of thrombosis in World Health Organization- essential thrombocythemia (IPSET-thrombosis). Blood 2012;120:5128-5133.
14. Barbui T, Thiele J, Passamonti F, et al. Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: An international study. J Clin Oncol 2011;29:3179-3184.
15. Campbell PJ, MacLean C, Beer PA, et al. Correlation of blood counts with vascular complications in essential thrombocythemia: Analysis of the prospective PT1 cohort. Blood 2012;120:1409-1411.
16. Passamonti F, Thiele J, Girodon F, et al. A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: A study by the International Working Group on Myelofibrosis Research and Treatment. Blood 2012;120:1197-1201.